🇺🇸 FDA
Patent

US 11459381

Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

granted A61KA61K2039/505

Quick answer

US patent 11459381 (Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof) held by UNIVERSITY OF CONNECTICUT expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505